Novo Integrated Sciences, Inc. (NVOS)
USD 0.07
(2.79%)
USD 0.07
(2.79%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -8.55 Million USD | 65.82% |
| 2022 | -25.02 Million USD | -472.23% |
| 2021 | -4.37 Million USD | -2.6% |
| 2020 | -4.26 Million USD | -442.59% |
| 2019 | -785.59 Thousand USD | 49.94% |
| 2018 | -1.56 Million USD | -1288.33% |
| 2017 | -113.04 Thousand USD | 31.44% |
| 2016 | -164.88 Thousand USD | 58.94% |
| 2015 | -401.57 Thousand USD | 29.9% |
| 2014 | -572.88 Thousand USD | -84.01% |
| 2013 | -311.33 Thousand USD | 61.96% |
| 2012 | -818.53 Thousand USD | 63.2% |
| 2011 | -2.22 Million USD | 4.53% |
| 2010 | -2.32 Million USD | -17.65% |
| 2009 | -1.98 Million USD | -105.53% |
| 2008 | -963.45 Thousand USD | 61.24% |
| 2007 | -2.48 Million USD | -69.91% |
| 2006 | -1.46 Million USD | -37.02% |
| 2005 | -1.06 Million USD | -355.39% |
| 2004 | -234.44 Thousand USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q3 | -2.52 Million USD | -63.67% |
| 2024 Q1 | -3.31 Million USD | -7.23% |
| 2024 Q2 | -1.53 Million USD | 53.59% |
| 2023 Q1 | -2.24 Million USD | 88.98% |
| 2023 Q4 | -3.09 Million USD | -116.3% |
| 2023 FY | -8.55 Million USD | 65.82% |
| 2023 Q3 | -1.43 Million USD | 19.95% |
| 2023 Q2 | -1.78 Million USD | 20.3% |
| 2022 FY | -25.02 Million USD | -472.23% |
| 2022 Q1 | -1.36 Million USD | 27.77% |
| 2022 Q4 | -20.33 Million USD | -1591.1% |
| 2022 Q3 | -1.2 Million USD | 43.28% |
| 2022 Q2 | -2.12 Million USD | -55.51% |
| 2021 Q1 | -757.72 Thousand USD | 80.85% |
| 2021 Q3 | -401.97 Thousand USD | 69.68% |
| 2021 Q4 | -1.88 Million USD | -369.65% |
| 2021 FY | -4.37 Million USD | -2.6% |
| 2021 Q2 | -1.32 Million USD | -74.99% |
| 2020 FY | -4.26 Million USD | -442.59% |
| 2020 Q1 | -76.82 Thousand USD | 82.07% |
| 2020 Q2 | -150.76 Thousand USD | -96.25% |
| 2020 Q3 | -78.55 Thousand USD | 47.9% |
| 2020 Q4 | -3.95 Million USD | -4936.8% |
| 2019 Q1 | -215.35 Thousand USD | -130.41% |
| 2019 FY | -785.59 Thousand USD | 49.94% |
| 2019 Q4 | -428.43 Thousand USD | -578.67% |
| 2019 Q2 | -78.68 Thousand USD | 63.46% |
| 2019 Q3 | -63.12 Thousand USD | 19.77% |
| 2018 FY | -1.56 Million USD | -1288.33% |
| 2018 Q4 | -93.46 Thousand USD | 47.15% |
| 2018 Q3 | -176.83 Thousand USD | 84.31% |
| 2018 Q2 | -1.12 Million USD | -553.69% |
| 2018 Q1 | -172.37 Thousand USD | -554.89% |
| 2017 FY | -113.04 Thousand USD | 31.44% |
| 2017 Q4 | 37.89 Thousand USD | 114.53% |
| 2017 Q3 | -260.87 Thousand USD | -654.16% |
| 2017 Q2 | 47.07 Thousand USD | 210.84% |
| 2017 Q1 | -42.47 Thousand USD | -13.86% |
| 2016 FY | -164.88 Thousand USD | 58.94% |
| 2016 Q4 | -37.3 Thousand USD | -118.78% |
| 2016 Q1 | 47.42 Thousand USD | 200.37% |
| 2016 Q2 | -68.06 Thousand USD | -243.51% |
| 2016 Q3 | -17.05 Thousand USD | 74.95% |
| 2015 Q2 | -45.42 Thousand USD | -133.64% |
| 2015 Q4 | -47.25 Thousand USD | 86.74% |
| 2015 FY | -401.57 Thousand USD | 29.9% |
| 2015 Q3 | -356.31 Thousand USD | -684.36% |
| 2015 Q1 | -19.44 Thousand USD | 85.05% |
| 2014 Q3 | -182.13 Thousand USD | -324.35% |
| 2014 FY | -572.88 Thousand USD | -84.01% |
| 2014 Q1 | -76.96 Thousand USD | 25.28% |
| 2014 Q2 | -42.92 Thousand USD | 44.23% |
| 2014 Q4 | -130.02 Thousand USD | 28.61% |
| 2013 FY | -311.33 Thousand USD | 61.96% |
| 2013 Q1 | 108.53 Thousand USD | 164.56% |
| 2013 Q2 | -100.9 Thousand USD | -192.97% |
| 2013 Q4 | -102.99 Thousand USD | 38.31% |
| 2013 Q3 | -166.94 Thousand USD | -65.45% |
| 2012 Q4 | -168.11 Thousand USD | 52.65% |
| 2012 Q3 | -355.07 Thousand USD | 11.65% |
| 2012 FY | -818.53 Thousand USD | 63.2% |
| 2012 Q1 | -410.25 Thousand USD | 18.18% |
| 2012 Q2 | -401.87 Thousand USD | 2.04% |
| 2011 FY | -2.22 Million USD | 4.53% |
| 2011 Q3 | -481.15 Thousand USD | 42.13% |
| 2011 Q4 | -501.4 Thousand USD | -4.21% |
| 2011 Q1 | -423.73 Thousand USD | -419.3% |
| 2011 Q2 | -831.4 Thousand USD | -96.21% |
| 2010 Q1 | -785.6 Thousand USD | -34.98% |
| 2010 Q4 | -81.59 Thousand USD | 93.03% |
| 2010 Q2 | -654.41 Thousand USD | 16.7% |
| 2010 Q3 | -1.16 Million USD | -78.78% |
| 2010 FY | -2.32 Million USD | -17.65% |
| 2009 Q3 | -319.43 Thousand USD | -8.97% |
| 2009 FY | -1.98 Million USD | -105.53% |
| 2009 Q4 | -582.03 Thousand USD | -82.21% |
| 2009 Q2 | -293.13 Thousand USD | 13.42% |
| 2009 Q1 | -338.57 Thousand USD | -25.78% |
| 2008 Q1 | -852.99 Thousand USD | -75.24% |
| 2008 Q4 | -269.18 Thousand USD | -51.6% |
| 2008 FY | -963.45 Thousand USD | 61.24% |
| 2008 Q2 | -178.12 Thousand USD | 79.12% |
| 2008 Q3 | -177.56 Thousand USD | 0.32% |
| 2007 Q4 | -486.74 Thousand USD | -3.3% |
| 2007 Q1 | -517.26 Thousand USD | 7.77% |
| 2007 Q3 | -471.18 Thousand USD | 30.16% |
| 2007 FY | -2.48 Million USD | -69.91% |
| 2007 Q2 | -674.67 Thousand USD | -30.43% |
| 2006 FY | -1.46 Million USD | -37.02% |
| 2006 Q3 | -259.37 Thousand USD | -106.76% |
| 2006 Q1 | -278.11 Thousand USD | -132.09% |
| 2006 Q2 | -125.44 Thousand USD | 54.9% |
| 2006 Q4 | -560.81 Thousand USD | -116.22% |
| 2005 FY | -1.06 Million USD | -355.39% |
| 2005 Q2 | -236.58 Thousand USD | 0.0% |
| 2005 Q4 | -119.83 Thousand USD | 72.33% |
| 2005 Q3 | -433.11 Thousand USD | -83.07% |
| 2004 FY | -234.44 Thousand USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 506.59 Million USD | 101.688% |
| Addus HomeCare Corporation | 90.95 Million USD | 109.404% |
| AirSculpt Technologies, Inc. | 9.48 Million USD | 190.195% |
| Amedisys, Inc. | 156.39 Million USD | 105.469% |
| American Oncology Network, Inc. | -49.15 Million USD | 82.599% |
| Astrana Health, Inc. | 84.61 Million USD | 110.109% |
| Aveanna Healthcare Holdings Inc. | 8.07 Million USD | 205.961% |
| IMAC Holdings, Inc. | -6.37 Million USD | -34.157% |
| biote Corp. | 28.65 Million USD | 129.847% |
| Cryo-Cell International, Inc. | -12.3 Million USD | 30.485% |
| Cross Country Healthcare, Inc. | 112.71 Million USD | 107.588% |
| COMPASS Pathways plc | -136.91 Million USD | 93.753% |
| DocGo Inc. | 15.05 Million USD | 156.813% |
| The Ensign Group, Inc. | 255.36 Million USD | 103.349% |
| Healthcare Services Group, Inc. | 62.35 Million USD | 113.716% |
| InnovAge Holding Corp. | -23.18 Million USD | 63.101% |
| Assure Holdings Corp. | -20.08 Million USD | 57.409% |
| The Joint Corp. | -2.07 Million USD | -312.581% |
| LifeStance Health Group, Inc. | -189.13 Million USD | 95.478% |
| Mobile-health Network Solutions Class A Ordinary Shares | -15.7 Million USD | 45.534% |
| ModivCare Inc. | -139.94 Million USD | 93.888% |
| NewGenIvf Group Limited | 42.24 Thousand USD | 20348.004% |
| Option Care Health, Inc. | 314.59 Million USD | 102.719% |
| P3 Health Partners Inc. | -167.86 Million USD | 94.905% |
| P3 Health Partners Inc. | -167.86 Million USD | 94.905% |
| The Pennant Group, Inc. | 25.16 Million USD | 133.983% |
| Surgery Partners, Inc. | 328 Million USD | 102.608% |
| Syra Health Corp. Class A Common Stock | -2.88 Million USD | -196.203% |
| Talkspace, Inc. | -23.2 Million USD | 63.147% |
| Talkspace, Inc. | -23.2 Million USD | 63.147% |
| The Oncology Institute, Inc. | -77.01 Million USD | 88.895% |
| The Oncology Institute, Inc. | -77.01 Million USD | 88.895% |